
Specialty finance company Hercules Capital (NYSE:HTGC) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 18.4% year on year to $141.5 million. Its non-GAAP profit of $0.48 per share was in line with analysts’ consensus estimates.
Is now the time to buy HTGC? Find out in our full research report (it’s free for active Edge members).
Hercules Capital (HTGC) Q1 CY2026 Highlights:
- Revenue: $141.5 million vs analyst estimates of $141.5 million (18.4% year-on-year growth, in line)
- Adjusted EPS: $0.48 vs analyst estimates of $0.47 (in line)
- Adjusted Operating Income: $88.11 million (62.3% margin, 13.8% year-on-year growth)
- Operating Margin: 62.3%, down from 64.8% in the same quarter last year
- Market Capitalization: $3.06 billion
StockStory’s Take
Hercules Capital delivered first quarter results that were in line with Wall Street expectations, with management crediting disciplined credit underwriting and record origination activity as key drivers. CEO Scott Bluestein emphasized that the company’s balance sheet and liquidity position remained strong despite a volatile market backdrop. He highlighted a deliberate focus on permanent capital structure and asset diversification, noting, “Our portfolio credit performance remains stable and our investment portfolio continued to generate net investment income in Q1 that comfortably covered our base shareholder distribution by 120%.”
Looking ahead, Hercules Capital’s outlook is shaped by expectations for continued market volatility but also robust origination opportunities. Management pointed to a high bar for new deals, ongoing portfolio diversification, and a deliberate shift toward more conservative structures—particularly in technology and life sciences sectors. Bluestein stated, “We will maintain a high bar for new originations. Our investment teams are continuing to update our modeling assumptions, structuring and underwriting criteria given the rapid pace of change across the technology ecosystem.” The company remains focused on managing leverage and maintaining flexibility to redeploy capital as prepayments increase, especially amid anticipated M&A activity.
Key Insights from Management’s Remarks
Hercules Capital’s first quarter was driven by record origination activity, stable credit performance, and a strong liquidity position, with a balanced approach to technology and life sciences exposures supporting results.
- Record origination momentum: Management reported all-time record new debt and equity commitments of $1.81 billion in Q1, attributing this growth to robust demand for both its public business development company (BDC) and private credit funds.
- Defensive asset allocation: The portfolio was intentionally weighted towards life sciences in the quarter, with 56% of new commitments and 60% of fundings going to companies in this sector. This reflects a cautious approach given market uncertainty, while still maintaining significant exposure to technology.
- Credit quality stability: Hercules highlighted stable portfolio credit metrics, with a weighted average internal credit rating of 2.11 and low levels of nonaccrual loans. Management emphasized that “our rated 4 and 5 credits as of Q1 were a combined 0.9%, the lowest since Q2 2022.”
- PIK income management: The company noted a meaningful decline in payment-in-kind (PIK) interest as a share of total revenue, emphasizing that most PIK income came from original underwriting rather than distressed amendments. Management is actively reducing PIK exposure on new deals, aiming for a greater share of cash interest income.
- Leadership transition: CFO Seth Meyer will become President, with Andrew Olson returning as CFO. Management sees this expansion as supporting the next phase of growth, citing Olson’s experience in alternative assets and private credit as a strategic addition.
Drivers of Future Performance
Management expects a robust origination environment, ongoing portfolio diversification, and disciplined credit standards to shape performance, while heightened prepayments and sector volatility present both opportunities and risks.
- Elevated prepayment activity: Management anticipates significant prepayments, largely driven by M&A events, which will provide flexibility for redeploying capital into new opportunities. Meyer stated that the majority of these prepayments “is coming from known M&A events that have either already happened or that we expect to happen in Q2.”
- Portfolio repositioning: As repayments free up capital, Hercules expects to rebalance its portfolio, maintaining but not increasing exposure to software. The company aims to diversify into other technology subsectors such as defense tech, network communications, and business services, while continuing to prioritize life sciences.
- Focus on underwriting discipline: The investment team is prioritizing structure over yield in new deals, emphasizing tighter covenants and custom-tailored solutions to manage risk, particularly in a market affected by AI disruption and regulatory shifts in life sciences.
Catalysts in Upcoming Quarters
Looking ahead, the StockStory team will be monitoring (1) the pace and quality of capital redeployment following elevated prepayments, (2) continued credit performance and nonaccrual trends amid sector volatility, and (3) the effectiveness of portfolio diversification as market conditions evolve. Developments in AI disruption and regulatory changes in life sciences will also be key to tracking Hercules’ execution.
Hercules Capital currently trades at $16.53, in line with $16.57 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.